CD155 blockade enhances allogeneic natural killer cell-mediated antitumor response against osteosarcoma.
Cho MM, Song L, Quamine AE, Szewc F, Shi L, Ebben JD, Turicek DP, Kline JM, Burpee DM, Lafeber EO, Phillips MF, Ceas AS, Bates PD, Forsberg MH, Kink JA, Erbe AK, Capitini CM.
Cho MM, et al.
J Immunother Cancer. 2025 Apr 15;13(4):e008755. doi: 10.1136/jitc-2023-008755.
J Immunother Cancer. 2025.
PMID: 40234092
Free PMC article.